General Electric Co. (GE, Financial): Senior Vice President Jeffrey S. Bornstein bought 5,000 shares
Bornstein bought 5,000 shares of GE stock on Jan. 31 at the average price of $29.63 per share. The price of the stock has increased by 0.17% since.
General Electric is an American international conglomerate corporation and operates through multiple segments, including Power & Water, Oil and Gas, Aviation, Healthcare and Transportation. The company has over 305,000 employees as of 2015 and ranked among the Fortune 500 as the 68th largest firm in the U.S. as of 2011. The company has a market cap of $262.74 billion, and as of Feb. 3 the company traded at $29.70.
On Feb. 2, General Electric announced that this year it will complete the modernization of Elektro Privreda Srbije’s TPP Nikola Tesla, the largest coal-fired power plant in Serbia that generates a large portion of the power supply for the national Serbian power grid. The retrofit will help increase power output, reduce operation and maintenance costs, and lower the plant’s carbon footprint through lower coal consumption.
Abbott Laboratories (ABT, Financial): Executive Vice President Stephen R. Fussell bought 12,200 shares
Fussell bought 12,200 shares of ABT stock on Jan. 31 at the average price of $40.77 per share. The price of the stock has increased by 4.86% since.
Executive Vice President Heather L. Mason sold 35,700 shares of ABT stock on Jan. 31 at the average price of $40.77. The price of the stock has increased by 4.86% since.
Abbott Laboratories is an American-based international health care company. It has more than 74,000 employees in 150 countries. Some of its products include pharmaceutical drugs, medical devices and nutritional products. The company has a market cap of $73.85 billion, and as of Feb. 3 it traded at $42.78.
On Feb. 2, Abbott Laboratories announced that the U.S. Federal Drug Administration has authorized its molecular test to detect Zika virus in whole blood collected alongside a patient-matched serum or plasma sample for emergency use. This is the first molecular test made by a commercial manufacturer authorized to detect Zika in whole blood samples.
WESCO International Inc. (WCC, Financial): SVP and CFO David S. Schulz bought 5,000 shares
Schulz bought 5,000 shares of WCC stock on Jan. 31 at the average price of $71.17 per share. The price of the stock has decreased by 1.01% since.
WESCO International Inc. is an American international holding company that provides electrical, industrial, communications, repair and original equipment product services. The company serves over 100,000 customers worldwide, including both commercial and government agencies. The company has a market cap of $3.46 billion, and as of Feb. 3 it traded at $71.30.
On Jan. 26, WESCO International Inc. reported financial results for the fourth quarter and full year 2016. Net sales were $1.78 billion for the quarter, compared to $1.86 billion for the fourth quarter of 2015, a decrease of 3.7%. Operating profit was $82.1 million for the current quarter, compared to $90 million for the fourth quarter of 2015.
Chemical Financial Corp. (CHFC, Financial): Director James R. Fitterling bought 1,500 shares
Fitterling bought 1,500 shares of CHFC stock on Jan. 30 at the average price of $48.57 per share. The price of the stock has increased by 1.98% since.
Director Ronald A. Klein sold 5,000 shares of CHFC stock on Jan. 31 at the average price of $48.88 per share. The price of the stock has increased by 1.33% since.
Chemical Financial is an American financial holding company that operates through one state-chartered traditional subsidiary bank. It is the largest banking company headquartered in Michigan, and offers both traditional banking and fiduciary products to residents and business customers through several states including Michigan, Ohio and Indiana. The company has a market cap of $3.5 billion, and as of Feb. 3 it traded at $49.53.
On Jan. 23, Chemical Financial announced that Jeffrey L. Tate, corporate auditor for the Dow Chemical company, was appointed to the board of directors. His appointment will increase the board size to 13 members and will be effective March 1. Tate began his Dow career in 1992 and has held a variety of accounting and controller roles in financial and leadership assignments in Dow Automotive and Investor Relations.
For the complete list of stocks that were bought by their company executives, go to: Insider Trades.
Disclosure: I do not own stock in any of the companies mentioned in the article.
Start a free seven-day trial of Premium Membership to GuruFocus.Â
